These immunophenotypic markers help differentiate it from other aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), which often shows a lower Ki-67 index and variable expression of BCL6 and BCL2. Here, BCL2 is linked to diffuse large B-cell lymphoma.